Drugs / human fetal neuroblasts
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00190450 | Jan 2002 → Dec 2013 | Huntington disease | Assistance Publique - Hôpitaux de Paris | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human fetal neuroblasts | “patients were grafted with human fetal neuroblasts into the right striatum then, after a year, the left striatum.” PMID 11130527 ↗ Dec 2000 |
| Action | Restore | “a substitution of the striatal neurons degenerated among a large cohort of Huntington's patient at early stage by homologous neurons coming from human foetuses” NCT00190450 ↗ |
| Modality | Cell therapy | “Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial.” PMID 32666599 ↗ Jul 2020 |
| Route | Other | “intrastriatal transplantation of fetal striatal neuroblasts” PMID 11130527 ↗ Dec 2000 |